IQVIA
Overland Park, Kansas, 66211, United States
NCT Number: NCT05872035
Validation of non-inferiority between headphone amplification settings determined by a participant and settings established by audiologist best practices in individuals 18 years or older.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Overland Park, Kansas, 66211, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Amplification settings established by algorithm and further adjusted by participants per their preference
Amplification settings established by clinical reference and further adjusted by an audiologist per current best practice
Time frame: Approximately 18-31 days upon enrollment
The IOI-HA survey is a 7-item questionnaire that assesses the effectiveness of hearing aids. It was self-administered to each study participant one time at the third scheduled clinic visit approximately 18-31 days after enrollment. For each participant, the IOI-HA total score (which ranges from 7-35 where higher scores indicate a better outcome) was computed and the mean IOI-HA scores were compared between the Experimental and Reference Groups.
Apple Inc.
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07309354
Hearing, Reflex, Acoustic
Uşak, Merkez, Turkey (Türkiye)
View Trial DetailsNCT06176625
Behavior, Behavioral Symptoms
Baltimore, Maryland, United States
View Trial DetailsNCT07254442
COVID - 19, COVID-19
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT05744830
Hearing
Damascus, Damascus Governorate, Syria
View Trial Details